Kintor Pharmaceutical Limited

HK$1.38As of Sun 8 Nov 2026, 12:00 UTC
HKEX:9939Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (30.54%)
Div yield —
ROE (118.45%)
Biotechnology
Beta (5Y) (0.43)
PE TTM —
TSR TTM (26.60%)
Mkt cap HK$681.5M
ROIC (39.43%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.68
21.46%
69.81%
Buy 10|2|5|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.01
0.02
0.02
0.02
7.73%
7.51%
11.38%
10.26%
Revenue¥M
48.71
48.62
51.18
53.29
2.49%
5.08%
8.37%
11.20%
Peers (US$86.92M)
Cap (US$)
PE
81.72M
—
Capital
TTM
5Y
10Y
Leveragex
1.348
0.328
0.272
EBIT/Intx
1.017
2.999
3.487
Own earn%
8.08
(114.87)
(111.38)
Sh yield%
31.56
16.00
15.02
Owners
Insiders/Inst%
11.24
46.29
Short interest%
4.78
SBC / revenue%
5.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
0–4
$1 testx
—
Incr. ROIC%
7